Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Very interesting article and data, well worth a read
Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854317/
We only need to 10 bag to get back to Ā£1.50, š«¤
What a fooking shambles. I donāt think the BOD have any interest in the PIās. They are probably busy working out if they can ring fence the IP and prevent it being sold off to settle any creditors claims. Is a Pre-pack administration a possibility if they are delisted? Tim and John wonāt want their work to just disappear, plus 737 has potential value. The longer the silence the more I suspect we will get shafted.
Aber, Iām sure news will come in due course. The BOD are having a meeting today around the camp fire at their new HQ. The communication issue is due the Wi-Fi not operating very well inside the tents that are the new offices. But on the bright side this keeps the overheads down and they donāt need to worry about keeping the lights on as there arenāt any. All is Rosie.
What a Pea nus.
Can you imagine what it must feel like as a person to know you make a living like this? I wonder if Robin goes to bed dreaming about those people he seeās who have friends and relationships. Because I doubt very much anyone would want to spend time with him. Sad really.
If Fred were only entitled to a fixed number of shares, he would have NO incentive or desire to see the stock price decline. In our previous example, Fred and his group has a moving target on the number of total shares, incentivizing the āinvestorsā into manipulating the stock downward. Even if the price of the stock dips, the investors still make their money back. Hereās the real catch: the investors now short the stock, covering their short positions with their convertible debenture at any time, regardless of the price of the stock. This is especially egregious and easy to do with microcap stocks where the stock is thinly-traded with little to no public float. The āinvestorsā can more easily significantly drive the price downward by selling short.
In a famous case in 2003, Thomas Newkirk, then the Associate Director of the SECās Division of Enforcement, stated the following in relation to toxicity of ādeath spiralā finance:
Certain convertible securities, particularly those referred to as ātoxicā or ādeath spiralā convertibles, present the temptation for persons holding the convertible securities to engage in manipulative short selling of the issuer's stock in order to receive more shares at the time of conversion.
Manipulators of this type rarely get away with such a scheme without collusive, stupid or desperate company owners. Legitimate, institutional investors donāt typically come calling until the share price reaches at least the $4 level. Even then, one must be cautious and perform relevant due diligence on the terms of an convertible debenture. Even desperate company managers who knowingly allow such shorts to happen run the risk of later unwanted action by regulators. In all, itās best not to even contemplate playing in the mud, otherwise youāre liable to get very dirty. In other words, work on building a great company, instead of using fanciful financial engineering to attempt to make a quick buck.
Dr Tim Mitchell, CEO of Sareum, commented:
"With a newly agreed funding facility designed to support Sareum through the Phase 1 study of its lead programme, SDC-1801, and good initial progress on the Phase 1a part of the trial, Sareum has begun the new financial year with significant momentum.ā¦ā¦ā¦ā¦ā¦ā¦
Tim I think itās time to explain whatās happening ref momentum.
Looking good for a blue finishā¦ā¦
Probably as likely as buy out above Ā£50m
Must say Iām surprised at the level of buying. Either thereās someone out there who knows something we donāt or thereās a never ending supply of punters as daft as us š